BioSpace News Archive

Feb. 20, 2020 21:05 UTC LEXINGTON, Mass.--( BUSINESS WIRE )-- Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the Company will release its fourth quarter and full year 2019 financial results after market close on Thursday, Feb. 27, 2020. Management will host a conference call at 4:30 p.m. ET that day to discuss the Company’s financial results and provide a general b

Feb. 20, 2020 21:07 UTC LOS ANGELES--( BUSINESS WIRE )-- Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2019. Unless otherwise stated, all comparisons are for the fourth quarter and full year 2019, compared to the fourth quarter and full year 2018. Product revenue, net consists entirely of sales revenue from NERLYNX®, Puma’s first commercial product. Net product revenue in th

BOSTON , Feb. 20, 2020 /PRNewswire/ -- In response to the growing impact of severe storms and flooding in several Southern U.S. states, Blue Cross Blue Shield of Massachusetts (“Blue Cross”) is expanding its offer of expedited access to care to members in Mississippi and Alabama who may be affected by flooding. This allows memb

Select Medical Holdings Corporation announced results for its fourth quarter and year ended December 31, 2019.

OAKVILLE, ON , Feb. 20, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (“Cipher” or “the Company”) today announced the details of its Q4 2020 financial results conference call on Thursday, March 26, 2019 . CONFERENCE CALL DETAILS DATE: Thursday, March 26, 2020 TIME: 8:30 a.m.

NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, March 5, 2020 after release of year end financial results. Participating on the call will be Dr. Phil Gomez, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcas

LaVoieHealthScience, an integrated investor and public relations consulting agency focused on advancing health and science innovations, announced the expansion of its New York and Boston presence with new hires and promotions.

NEW YORK , Feb. 20, 2020 /PRNewswire/ -- JDRF, a global leader in type 1 diabetes (T1D) research, today announced the appointment of two long-time volunteers to lead its International Board of Directors (IBOD). The two take office when the terms of current board leaders expire July 1, 2020 . JDRF’s IBOD named Joseph P. Lacher, Jr. ,

Feb. 20, 2020 18:04 UTC SOMERSET, N.J.--( BUSINESS WIRE )-- Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc. (the “Operating Subsidiary”), priced a private offering (the “Private Offering”) of €825.0 million in aggregate principa

The board of directors of AbbVie Inc. declared a quarterly cash dividend of $1.18 per share..